Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Tunis Med ; 92(1): 12-7, 2014 Jan.
Artículo en Francés | MEDLINE | ID: mdl-24879164

RESUMEN

BACKGROUND: Since few years, the data describing the chronic obstructive pulmonary disease (COPD) have changed and new concepts have emerged. AIM: To study the clinical characteristics and outcome of patients with COPD in a Tunisian population. METHODS: It is a retrospective study including 150 patients with COPD admitted at the pulmonary department of Charles Nicolle Hospital in Tunis, during a period of ten years. RESULTS: Data from 150 patients hospitalized at the pulmonary department of Charles Nicolle Hospital in Tunis, were analyzed. They were 126 men and 24 women with a mean age of 67 years. Tobacco was the predominant risk factor. Eighty-two (55%) patients were classified GOLD stage IV at diagnosis. The number of exacerbation varied from 1 to 7 with an average higher in patients classified as stage IV (p = 0.007). CONCLUSION: The COPD is pathology of smoking men. Comorbidities and exacerbations prevalence increase according the disease severity. In fact, better knowledge of exacerbations etiologies allows considering better measurement of prevention.


Asunto(s)
Hospitalización/estadística & datos numéricos , Enfermedad Pulmonar Obstructiva Crónica/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Enfermedad Pulmonar Obstructiva Crónica/terapia , Estudios Retrospectivos , Túnez/epidemiología
2.
Rev Mal Respir ; 37(1): 8-14, 2020 Jan.
Artículo en Francés | MEDLINE | ID: mdl-31899023

RESUMEN

INTRODUCTION: Obstructive sleep apnoea (OSA) is commonly associated with non-alcoholic fatty liver disease (NAFLD). Early identification of NAFLD in OSA patients is important in order to try to prevent its evolution to advanced stages. The objective of this study was to determine the prevalence and risk factors for the occurrence of NAFLD in OSA patients. METHOD: A cross-sectional analysis including 124 OSA patients examined in the pulmonology department of Abderahmane Mami Hospital between January 2017 and March 2018 was undertaken. NAFLD was diagnosed using an abdominal ultrasonography. Data were analysed in a univariate and multivariate fashion in order to determine the characteristics of OSA patients with and without NAFLD. RESULTS: NAFLD was found in 62.9 % patients, with a frequency according to OSA severity of 51.3 %, 56.5 % and 72.6 % in mild, moderate and severe OSA, respectively. Severe OSA multiplies by 2.32 the risk of having NAFLD. The comparison between groups with and without NAFLD reveals that patients with the disease were younger, more obese, had more severe OSA, lower nocturnal oxygen saturation during sleep, and higher ALAT levels. Multivariate analysis showed a statistically significant link between NAFLD and serum ALAT elevation and the oxygen desaturation index. CONCLUSIONS: NAFLD is a frequent comorbidity in OSA, correlated to the severity of the disease. Thus, early screening of the disease in OSA patients especially in younger obese patients with high ALAT serum levels and a high oxygen desaturation index is proposed.


Asunto(s)
Enfermedad del Hígado Graso no Alcohólico/complicaciones , Enfermedad del Hígado Graso no Alcohólico/epidemiología , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/epidemiología , Adulto , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/etiología , Prevalencia , Factores de Riesgo , Apnea Obstructiva del Sueño/etiología , Túnez/epidemiología , Adulto Joven
3.
Rev Pneumol Clin ; 74(2): 81-88, 2018 Apr.
Artículo en Francés | MEDLINE | ID: mdl-29523464

RESUMEN

BACKGROUND: Pneumothorax is a serious complication of cavitary pulmonary tuberculosis. The aim of this study was to describe clinical futures, to highlight challenges of its management. METHODS: A retrospective multicentric and descriptive study including 65 patients treated for PT (1999-2015) was conducted to figure out clinical futures and its work-up. RESULTS: The mean age was 37.8 years. The sex ratio was 3.6. Smoking history and incarceration were noted respectively in 67.6 and 15.3% of cases. Acute respiratory failure and cachexia were reported in 26.1 and 10.7% of cases. The PT was inaugural in 41.5% of cases. Pyo-pneumothorax was noted in 69.2% of cases. The duration of antituberculous treatment ranged from 6 to 15 months for susceptible TB and was at least 12 months for resistant TB (4 cases). Thoracic drainage was performed in 90.7% patients. Its average length was 47 days. The drain drop was noted in 20% of cases. Bronchopleural fistula was diagnosed in 6 cases and pleural infection in 5 of cases. Surgery treatment was necessary in 6 cases. Mean time to surgery was 171 days. Six patients had pleural decortication associated with pulmonary resection in 4 cases. Persistent chronic PT was noted in 12.6% and chronic respiratory failure in 3% of cases and death in 15.3% of cases. CONCLUSION: The diagnosis of the PT is often easy. Its treatment encounters multiples difficulties. Duration of thoracic drainage and anti-TB treatment are usually long. Surgery is proposed lately.


Asunto(s)
Antituberculosos/uso terapéutico , Drenaje/métodos , Neumotórax/terapia , Tuberculosis Pulmonar/complicaciones , Adulto , Tubos Torácicos/efectos adversos , Drenaje/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neumotórax/diagnóstico , Neumotórax/etiología , Estudios Retrospectivos , Adulto Joven
5.
Rev Pneumol Clin ; 71(2-3): 122-9, 2015.
Artículo en Francés | MEDLINE | ID: mdl-25434510

RESUMEN

The aim of this article is to give practicing physicians a practical approach to the treatment of latent and active tuberculosis. Most patients follow TB standard treatment recommended by WHO that depend on category of patient. It is a combination of four essential tuberculosis drugs of the first group: isoniazid, rifampicin, pyrazinamid and ethambutol; in some cases streptomycin can replace ethambutol. This initial phase of intensive treatment is followed by a consolidation phase. Drugs should be administered in the morning on an empty stomach one hour before meals. Treatment of latent tuberculosis (TB) infection is an important component of TB control programs. Preventive treatment can reduce the risk of developing active TB.


Asunto(s)
Antituberculosos/uso terapéutico , Etambutol/uso terapéutico , Isoniazida/uso terapéutico , Pirazinamida/uso terapéutico , Rifampin/uso terapéutico , Tuberculosis/tratamiento farmacológico , Quimioterapia Combinada , Humanos , Tuberculosis Latente/tratamiento farmacológico , Guías de Práctica Clínica como Asunto , Resultado del Tratamiento , Tuberculosis Pulmonar/tratamiento farmacológico , Organización Mundial de la Salud
6.
Int J Tuberc Lung Dis ; 6(12): 1123-7, 2002 Dec.
Artículo en Francés | MEDLINE | ID: mdl-12546123

RESUMEN

A tobacco cessation programme was recently introduced into medical practice in Tunisia. The medical staff in the pulmonary disease ward at Charles Nicolle Hospital, Tunis, has been the first to implement such a programme for people motivated to quit smoking. This programme has been run for 3 years in the respiratory disease out-patient department. It acts essentially against psychological and pharmacological dependence on tobacco. The results obtained were very encouraging: 298 smokers have participated in this programme. The global success rate at 12 months of tobacco withdrawal was about 25% for people who were followed up, and 17% for the whole sample. Medical help for smoking cessation should be more widely promoted in Tunisia to increase the number of smokers who consult and improve the quality of medical intervention.


Asunto(s)
Unidades Hospitalarias , Servicio Ambulatorio en Hospital , Evaluación de Programas y Proyectos de Salud , Cese del Hábito de Fumar/psicología , Tabaquismo/psicología , Tabaquismo/terapia , Adolescente , Adulto , Anciano , Niño , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Factores de Tiempo , Túnez
7.
J Mycol Med ; 22(3): 217-20, 2012 Sep.
Artículo en Francés | MEDLINE | ID: mdl-23518077

RESUMEN

UNLABELLED: Lung mycosis is rare. Diagnosis and treatment must be done the earliest possible. METHODS: It is about a retrospective study on clinical records including patients hospitalized for lung infection. RESULTS: From 2008 to 2011, 16 patients (13 men and three women, average age 42 years) developed a pulmonary infection. Twelve of our patients had respiratory or extrarespiratory histories. None of our patients had a neutropenia. The diagnoses were lung aspergilloma in four cases, invasive lung aspergillosis in three cases, allergic bronchopulmonary aspergillosis in three cases, mucormycosis in three cases, trichosporonosis in a case, actinomycosis in one case and penicilliosis in one case. An antifungal treatment consisting in amphotericin B or itraconazole was given to four patients and six patients, respectively. Surgery was chosen for six patients. The evolution was good for 12 patients, one presented renal failure, and three patients died.


Asunto(s)
Enfermedades Pulmonares Fúngicas/epidemiología , Adulto , Anciano , Antifúngicos/uso terapéutico , Terapia Combinada , Comorbilidad , Susceptibilidad a Enfermedades , Femenino , Humanos , Huésped Inmunocomprometido , Pacientes Internos/estadística & datos numéricos , Recuento de Leucocitos , Enfermedades Pulmonares Fúngicas/diagnóstico por imagen , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/inmunología , Enfermedades Pulmonares Fúngicas/cirugía , Masculino , Persona de Mediana Edad , Neutrófilos , Radiografía , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
9.
Rev Pneumol Clin ; 66(6): 355-8, 2010 Dec.
Artículo en Francés | MEDLINE | ID: mdl-21167444

RESUMEN

Bronchopulmonary sequestration is a rare malformation characterized by lung tissue fed by one or several aberrant systemic arteries. The authors present the case of a 35-year-old woman in whom extralobar sequestration was fortuitously detected at the time of persistent pleuropneumopathy. Computed tomography was used in the diagnosis of pulmonary sequestration. The most common and recommended treatment is the surgical removal of the pulmonary sequestration.


Asunto(s)
Secuestro Broncopulmonar/diagnóstico por imagen , Pleuroneumonía/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Antibacterianos/uso terapéutico , Secuestro Broncopulmonar/cirugía , Broncoscopía , Enfermedad Crónica , Quimioterapia Combinada , Femenino , Humanos , Hallazgos Incidentales , Ofloxacino/uso terapéutico , Pleuroneumonía/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA